1 completed, 1 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Terminated 1 |
Follow reslizumab: new trials by email Literature Review of reslizumab trials Research Report on reslizumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma Reslizumab - Asthma; Eosinophilic | Phase 4 | Completed | McMaster University | 10 | 2021-02-10 | 2024-01-25 |
| An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation Reslizumab, Fludeoxyglucose F 18 (FDG), Placebo - Asthma | Phase 4 | Terminated | Teva Branded Pharmaceutical Products R&D, Inc. | 5 | 2017-05-08 | 2021-11-09 |
Asthma (2) · Pulmonary Eosinophilia (1)
McMaster University (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1)
Canada (1) · United States (1)